Cargando…
COVID‐19 after BNT162b2 two‐dose primary series does not improve the efficacy of a booster dose in nursing home residents
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033849/ https://www.ncbi.nlm.nih.gov/pubmed/36973956 http://dx.doi.org/10.1002/clt2.12224 |
_version_ | 1784911077286346752 |
---|---|
author | Blain, Hubert Tuaillon, Edouard Gamon, Lucie Pisoni, Amandine Aouinti, Safa Picot, Marie‐Christine Bousquet, Jean |
author_facet | Blain, Hubert Tuaillon, Edouard Gamon, Lucie Pisoni, Amandine Aouinti, Safa Picot, Marie‐Christine Bousquet, Jean |
author_sort | Blain, Hubert |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10033849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100338492023-03-24 COVID‐19 after BNT162b2 two‐dose primary series does not improve the efficacy of a booster dose in nursing home residents Blain, Hubert Tuaillon, Edouard Gamon, Lucie Pisoni, Amandine Aouinti, Safa Picot, Marie‐Christine Bousquet, Jean Clin Transl Allergy Research Letter John Wiley and Sons Inc. 2023-03-22 /pmc/articles/PMC10033849/ /pubmed/36973956 http://dx.doi.org/10.1002/clt2.12224 Text en © 2023 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Letter Blain, Hubert Tuaillon, Edouard Gamon, Lucie Pisoni, Amandine Aouinti, Safa Picot, Marie‐Christine Bousquet, Jean COVID‐19 after BNT162b2 two‐dose primary series does not improve the efficacy of a booster dose in nursing home residents |
title | COVID‐19 after BNT162b2 two‐dose primary series does not improve the efficacy of a booster dose in nursing home residents |
title_full | COVID‐19 after BNT162b2 two‐dose primary series does not improve the efficacy of a booster dose in nursing home residents |
title_fullStr | COVID‐19 after BNT162b2 two‐dose primary series does not improve the efficacy of a booster dose in nursing home residents |
title_full_unstemmed | COVID‐19 after BNT162b2 two‐dose primary series does not improve the efficacy of a booster dose in nursing home residents |
title_short | COVID‐19 after BNT162b2 two‐dose primary series does not improve the efficacy of a booster dose in nursing home residents |
title_sort | covid‐19 after bnt162b2 two‐dose primary series does not improve the efficacy of a booster dose in nursing home residents |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033849/ https://www.ncbi.nlm.nih.gov/pubmed/36973956 http://dx.doi.org/10.1002/clt2.12224 |
work_keys_str_mv | AT blainhubert covid19afterbnt162b2twodoseprimaryseriesdoesnotimprovetheefficacyofaboosterdoseinnursinghomeresidents AT tuaillonedouard covid19afterbnt162b2twodoseprimaryseriesdoesnotimprovetheefficacyofaboosterdoseinnursinghomeresidents AT gamonlucie covid19afterbnt162b2twodoseprimaryseriesdoesnotimprovetheefficacyofaboosterdoseinnursinghomeresidents AT pisoniamandine covid19afterbnt162b2twodoseprimaryseriesdoesnotimprovetheefficacyofaboosterdoseinnursinghomeresidents AT aouintisafa covid19afterbnt162b2twodoseprimaryseriesdoesnotimprovetheefficacyofaboosterdoseinnursinghomeresidents AT picotmariechristine covid19afterbnt162b2twodoseprimaryseriesdoesnotimprovetheefficacyofaboosterdoseinnursinghomeresidents AT bousquetjean covid19afterbnt162b2twodoseprimaryseriesdoesnotimprovetheefficacyofaboosterdoseinnursinghomeresidents |